These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma. Weterman MA; van Muijen GN; Ruiter DJ; Bloemers HP Int J Cancer; 1993 Jan; 53(2):278-84. PubMed ID: 8425765 [TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148 [TBL] [Abstract][Full Text] [Related]
8. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. MacDougall JR; Bani MR; Lin Y; Rak J; Kerbel RS Cancer Res; 1995 Sep; 55(18):4174-81. PubMed ID: 7664294 [TBL] [Abstract][Full Text] [Related]
9. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma. Baba Y; Funakoshi T; Mori M; Emoto K; Masugi Y; Ekmekcioglu S; Amagai M; Tanese K J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2038-2045. PubMed ID: 28681540 [TBL] [Abstract][Full Text] [Related]
10. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression]. Ntayi C; Hornebeck W; Bernard P Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in human melanoma. Hofmann UB; Westphal JR; Van Muijen GN; Ruiter DJ J Invest Dermatol; 2000 Sep; 115(3):337-44. PubMed ID: 10951266 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma. de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958 [TBL] [Abstract][Full Text] [Related]
13. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806 [TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma. Vuoristo MS; Kellokumpu-Lehtinen P; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Laine S Acta Oncol; 2000; 39(7):877-9. PubMed ID: 11145448 [TBL] [Abstract][Full Text] [Related]
16. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma. Ren S; Smith MJ; Louro ID; McKie-Bell P; Bani MR; Wagner M; Zochodne B; Redden DT; Grizzle WE; Wang Nd; Smith DI; Herbst RA; Bardenheuer W; Opalka B; Schütte J; Trent JM; Ben-David Y; Ruppert JM Oncogene; 2000 Mar; 19(11):1419-27. PubMed ID: 10723133 [TBL] [Abstract][Full Text] [Related]
17. Possible diagnostic role of telomerase activity evaluation in the differential diagnosis between spitz naevi and cutaneous malignant melanoma. Tosi P; Miracco C; Santopietro R; Pacenti L; Perotti R; Materno M; Luzi P Br J Dermatol; 2000 May; 142(5):1060-1. PubMed ID: 10809882 [No Abstract] [Full Text] [Related]
18. Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases. Dennhöfer R; Kurschat P; Zigrino P; Klose A; Bosserhoff A; van Muijen G; Krieg T; Mauch C; Hunzelmann N Int J Cancer; 2003 Sep; 106(3):316-23. PubMed ID: 12845667 [TBL] [Abstract][Full Text] [Related]
19. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study. De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228 [TBL] [Abstract][Full Text] [Related]
20. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]